Clinical Trial Update: A Double-Blind, Randomized, Parallel, Comparative Study to Evaluate the Efficacy and Safety of an Antidiabetic Agent Repaglinide for the Treatment of Type 2 Diabetes Mellitus Patients [Phase 4]

View source ↗

Summary

A Phase 4 double-blind, randomized study assessing the efficacy and safety of repaglinide for treating Type 2 diabetes; current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Repaglinide (Repaglinide)

Snippet

Sponsor: National Cheng-Kung University Hospital | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: UNKNOWN